Shining a Light on Skin Cancer in Inflammatory Bowel Disease: A Role for Prevention.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32925196.
- Also identified by DOI 10.14309/ajg.0000000000000775.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Risks of nonmelanoma skin cancer in patients with inflammatory bowel disease (IBD) have been well described. Newer data have classified risks of subsequent squamous cell carcinoma or basal cell carcinoma in patients with IBD after an initial skin cancer excision. In this editorial, risks of continuing medical therapy for IBD after a skin cancer diagnosis are discussed in the context of a holistic preventive care approach for patients with IBD.
Medical subject headings
- Basal Cell Carcinoma
- Carcinoma, Squamous Cell
- Inflammatory Bowel Diseases
- Skin Neoplasms